Investor Relations
Recent Releases
Mar 15, 2010
Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux
Stock Information
| NYSE:LLY
$36.36 + 0.14 |
Mar 18, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.



